Mosby's 2023 nursing drug reference / Linda Skidmore-Roth
Material type: TextEdition: Thirty-sixth editionDescription: x, 1490 pages (5 unnumbered pages) ; 19 cmISBN: 9780323930727; 0323930727Other title: 2023 Nursing drug reference | Nursing drug reference | Mosby's nursing drug referenceSubject(s): Drugs -- Handbooks, manuals, etc | Nursing -- Handbooks, manuals, etc | Pharmacology | Drugs -- Dosage | Pharmaceutical Preparations -- administration & dosage | PharmacologyGenre/Form: Handbooks and manuals. DDC classification: 615.1 LOC classification: RM301.12 | .S59 2023RM301.12 | .S55 2023NLM classification: QV 39Current library | Call number | Copy number | Status | Date due | Barcode |
---|---|---|---|---|---|
Faculty Of Nursing & Health Sciences Library
Ruharo Campus |
615.1 SKI (Browse shelf (Opens below)) | 001 | Available | bsu24080628 |
Browsing Main Library shelves Close shelf browser (Hides shelf browser)
615.1 RAN Rang & Dale's pharmacology / | 615.1 RAN Rang & Dale's pharmacology / | 615.1 REM Remington : the science and practice of pharmacy / | 615.1 SKI Mosby's 2023 nursing drug reference / | 615.1 TUC Karch's focus on nursing pharmacology / | 615.1 VAR Synthesis of best-seller drugs / | 615.102 SEA Lilley's pharmacology for Canadian health care practice / |
Includes index
Individual drug monographs -- Appendixes: A. Selected new drugs:abametapir ; aducanumab-avwa ; afamelanotide ; anifrolumab-fnia ; asciminib ; atogepant ; avacopan ; avapritinib ; belumosudil ; belzutifan ; bempedoic acid ; brolucizumab-dbll ; difelikefalin ; dostarlimab-gxly - eculizumab ; efavirenz/emtricitabine/tenofovir ; elapegademase-ivir ; elbasvir/grazoprevir ; elexacaftor/tezacaftor/ivacaftor and ivacaftor ; emtricitabine/rilpivirine/tenofovir alafenamide ; enalapril/hydrochlorothiazide ; ephedrine ; factor IX, complex ; factor IX, human ; factor IX, recombinant ; finerenone ; fluocinolone ; fluocinonide ; lonapegsomatropin-tcgd ; loncastuximab tesirine-lpyl ; maribavir ; mobocertinib ; odevixibat ; ropeginterferon alfa-2b ; tisotumab vedotin-tfv ; vosoritide -- B. Ophthalmic, nasal, topical, and otic products -- C. Vaccines and toxoids -- D. Recent FDA drug approvals
Choose the drug handbook trusted by nurses for more than 35 years! Mosby's 2023 Nursing Drug Reference makes it easy to find the most vital information on the drugs you administer most frequently. More than 5,000 drugs are profiled -- including 35 new entries for drugs recently approved by the FDA. And no other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, Safety Alerts for situations requiring special attention, and a focus on both common and life-threatening side effects. From nursing pharmacology expert Linda Skidmore-Roth, this perennial bestseller proves there is a difference in drug guides
There are no comments on this title.